Introduction
Transmembrane transport of neutral amino acids in skeletal muscle is mediated by at least four different systems (system A, ASC, L, and N'), and may be an important target for insulin's effects on amino acid and protein metabolism. We have measured net amino acid exchanges and fractional rates of inward (ki, min') and outward (k*ot, min-) transmembrane transport of 2-methylaminoisobutyric acid (MeAIB, a nonmetabolizable amino acid analogue, specific for system A amino acid transport) in forearm deep tissues (skeletal muscle), by combining the forearm perfusion technique and a novel dual tracer ([1-H3J-D-mannitol and 2-[1-'4CJ-methylaminoisobutyric acid) approach for measuring in vivo the activity of system A amino acid transport. Seven healthy lean subjects were studied. After a baseline period, insulin was infused into the brachial artery to achieve local physiologic hyperinsulinemia (76±8,uU/ml vs 6.4±1.6 ,U/ml in the basal period, P < 0.01) without affecting systemic hormone and substrate concentrations. Insulin switched forearm amino acid exchange from a net output (-2,630±1,100 nmol/min per kg of forearm tissue) to a net uptake (1,610±600 nmol/min per kg, P < 0.01 vs baseline). Phenylalanine and tyrosine balances simultaneously shifted from a net output (-146±47 and -173±34 nmol/min per kg, respectively) to a zero balance (163±51 for phenylalanine and 15.5±14.3 nmol/min per kg for tyrosine, P < 0.01 vs baseline for both), showing that protein synthesis and breakdown were in equilibrium during hyperinsulinemia. Net negative balances of alanine, methionine, glycine, threonine and asparagine (typical substrates for system A amino acid transport) also were decreased by insulin, whereas serine (another substrate for system A transport) shifted from a zero balance to net uptake. Insulin increased kih of MeAIB from a basal value of 11.8 10-2+17 102. min to 13.7 10-2+2.10-2-min-I (P < 0.02 vs the postabsorptive value), whereas k.. was unchanged. We conclude that physiologic hyperinsulinemia stimulates the activity of system A amino acid transport in human skeletal muscle, and that this effect may play a role in determining the overall concomitant response of muscle amino acid/protein metabolism to insulin. (J. Clin. Invest. 1993. 91:514-521.) Key words: limb balance -2-methylaminoisobutyric acid -first-pass kinetics * protein turnover Elucidation ofthe mechanisms underlying the ability ofinsulin to promote an anabolic effect on protein metabolism in man has been the focus of a number of recently published studies (1) (2) (3) (4) (5) (6) (7) (8) . A large body of evidence has indicated that a major site of insulin action, as investigated by isotope techniques, is the inhibition of proteolysis (1) (2) (3) (4) (5) (6) (8) (9) (10) (11) (12) . Physiologic hyperinsulinemia has been shown to diminish protein degradation, both at the whole body level (1) (2) (3) (4) (5) (6) (8) (9) (10) (11) (12) and in skeletal muscle (13) (14) (15) (16) . Although insulin has been shown to augment protein synthesis in vitro (17) (18) (19) (20) (21) (22) , a similar anabolic effect in vivo has been difficult to demonstrate (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . With regard to this apparent discrepancy, by infusing tracer amino acids in vivo, one usually yields an estimate of bulk protein synthesis both at the whole body and at the regional level. Recent data suggest that insulin, while not affecting bulk protein synthesis in vivo, may exert opposite effects on the synthetic rates ofdifferent proteins in the body (23) .
Transmembrane transport of amino acids may play an important role in regulating protein balance in skeletal muscle (24) (25) . This is suggested by several observations. First, in the postabsorptive state most amino acids are concentrated in the intracellular compartment against their electrochemical gradient (7, 24, 25) . This phenomenon implies the operation of transport systems that actively maintain a transmembrane gradient. Second, insulin and other hormones (24) in vitro have been shown to enhance the translocation of some amino acids into the cell and an increase in intracellular amino concentration is known to stimulate protein synthesis (13, 26) .
At least four distinct transport systems named systems A, ASC, L, and Nm, respectively, mediate the transmembrane traffic of neutral amino acids (24, 25, 27, 28) . This definition ofthe amino acid transport systems is operational, inasmuch as it is based on the unique kinetic characteristics displayed by the transport ofnonmetabolizable amino acid analogues across the cell membrane in in vitro systems (24, 25) . While awaiting that the molecular identification ofthe carriers involved in the traffic ofanalogues and naturally occurring amino acids across the plasma membrane is achieved, this conventional nomenclature is a conceptual and semantic frame by which researchers denote those components ofamino acid transport that are inhibitable with and probed by analogues and/or naturally occurring substrates characterized by strict specificity for a single transport system. Systems A, ASC, and Nm are sodium dependent and maintain steep transmembrane gradients in amino acid concentrations. In contrast, system L does not require sodium to operate. All these systems display partial but not absolute specificity for their substrates. On practical grounds, this means that the transmembrane traffic of, say, methionine is simultaneously mediated by system A and system L, each ofwhich is independently regulated (24, 25) . Therefore, most amino acids are transported by more than one system and, conversely, each transport system carries many an amino acid with overlapping specificity. Since the transmembrane traffic of any single amino acid is mediated by more than one transport system and is further complicated by intracellular metabolism, the most straightforward way to investigate the activity of the various amino acid transport agencies is to measure the transmembrane transport of nonmetabolizable amino acid analogues strictly specific for the transport system of interest. Of such analogues, those which are believed to display the most stringent specificity are 2-methylaminoisobutyric acid (MeAIB)' for system A and 2-( -)-endoamino-bicycloheptane-2-carboxylic acid for system L (24, 25) . Since system A is known to be hormone sensitive (24, 28) , it seemed to us that in an attempt to elucidate the involvement of transmembrane transport in insulin action upon amino acid and protein metabolism of skeletal muscle in vivo, one should examine first the response of system A to insulin. However, no techniques are currently available to assess the activity in vivo oftransmembrane amino acid transport.
Recently, we developed a method to quantitate the activity oftransmembrane glucose transport in human skeletal muscle (29) by combining the forearm perfusion technique (30) (31) (32) with the multiple tracer dilution technique (33) . In the present study, we have applied the same strategy to assess the effect of insulin on transmembrane system A amino acid transport. Our findings show that physiologic hyperinsulinemia stimulates transmembrane inward amino acid transport by system A in human forearm muscle.
Methods
Subjects. Seven was rapidly (3 s) injected into the artery via the same syringe. Frequent blood samples (every 10-30 s) were drawn manually from the deep vein for 10 min thereafter. The midpoint ofthe collection time (6-8 s) was recorded for each blood sample, because owing to the inter-and intraindividual variability in the easiness ofblood collection, no predetermined time schedule was used for the sampling of the washout curves. In the computerized analysis ofthe washout curves, each single point was considered to be the weighted average oftracer concentration within the time window corresponding to the collection time. Forearm volume was determined by water displacement. Forearm density was assumed to be 1.
Analytical methods. Plasma insulin concentration was measured with a double antibody radioimmunoassay (4) . The concentrations of indocyanine green dye in infusate and plasma were measured spectrophotometrically at 810 nm ( 14, 15) . Plasma amino acid (taurine, aspartate, threonine, serine, asparagine, glutamate + glutamine, glycine, alanine, valine, half cystine, methionine, isoleucine, leucine, tyrosine, and phenylalanine) concentrations were measured in sulfosalicylic acid extracts of plasma using an automated ion exchange chromatographic technique (D-500; Dionex Corp., Sunnyvale, CA) (4). In five subjects, arterial and deep venous plasma potassium concentration was determined by flame spectrometry. Deep vein plasma samples collected after the tracer intraarterial injection were deproteinized according to Somogyi (36), dried, reconstituted, and mixed with scintillation fluid (Scintiverse; Fischer America, Inc., Waukesha, WI). Radioactivity was quantitated in a dual-channel liquid scintillation counter with external standard correction (Packard Instrument Co., Downers Grove, IL). Known volumes of all tracer infusates were added to plasma samples obtained from the same subject before the injection ofthe tracers, and plasma radioactivity was determined after Somogyi precipitation as described above.
Calculations. The net plasma exchange ofsubstrates across the forearm (37) To obtain detailed quantitative information from the dual tracer washout curves, we have developed a linear flow-compartmental model ofthe forearm system, which takes into account heterogeneities in properties, functions, and interactions between capillary-tissue units and measures amino acid transport into and out of the cell. A similar approach was recently proposed to measure glucose transport in the human forearm, to which the reader is referred for details on modeling rationale and methodology (29) . Various candidate model structures were tested to describe not only the kinetics of amino acid transport into and out ofthe cell, but also blood flow in the vascular structure and diffusion into the interstitial fluid. Since neither mannitol nor MeAIB permeate red blood cells (24, 25 ) , their extracellular kinetics are identical. The model, which was eventually chosen to analyze simultaneously the dual tracer washout curves is shown in Fig. 1 . Compart- ments I and 8 are the plasma compartments where tracer input (injection) and measurement take place and, therefore, represent the arterial and venous portions of the model. The capillary-interstitial fluid section is represented by the three parallel chains of compartments; i.e., compartments 2 Ad 3; 4 and 5; and 6 and 7. The three chains are characterized by different rates to account for blood flow heterogeneity. The tissue portion is described by cellular compartments, briefly labeled as i.c., that are appended to and in exchange with the correspondent extracellular compartments in each chain. Two fractional irreversible losses, k01 (min-') and kog (min-'), are present in the model. The former accounts for the fact that only a fraction of the injected dose reaches the sampling compartment. The intrinsic symmetry of the model was resolved by imposing the following constraint on the model parameters: k83>k85S>k87 (min-') () This corresponds to label the three chains as fast (compartments 2 and 3), intermediary (compartments 4 and 5) and slow (compartments 6 and 7), respectively. An additional constraint was needed to ensure a priori unique identifiability of the extracellular portion of the model: k32 =k83; k54 =k85; k76 =k87 (2) Finally, all the rate constants characterizing fractional MeAIB transport into the cell and those out of the cell in the three chains of compartments were assumed to be identical and named kn and k05,, respectively. It can be shown that ks, and k0., are a priori uniquely identifiable (29) . The a priori uniquely identifiable parameterization ofthe model was fitted for each individual data set by using nonlinear least-squares parameter estimation. Measurement error was assumed additive, uncorrelated, of zero mean and with an experimentally determined variance. Coefficients of variation ranged from 1 to 6-8% and were higher with lower counts. The conversational version (CONSAM) of the SAAM program was used in model parameter estimation (38, 39) . In all cases, model fit was very good and the transport rate parameters were estimated with good precision. The median coefficients of variation of ki, were 5% (range: 3-11%) in the basal state and 6% (range: 4-10%) during hyperinsulinemia, respectively. The median coefficients of variation of k0., were 1 1% (range: 5-26%) in the basal state and 19% (range: 4-46%) during hyperinsulinemia, respectively.
The transfer of MeAIB into and out of the cell takes place in the presence ofseveral other amino acids which are substrates for the same transport process. These amino acids act as competitive inhibitors of MeAIB transport. It is ofinterest to explore the mathematical relationship between the fractional rates ofMeAIB transport (ki,, and k05,) and the kinetic parameters of system A transport. Let's focus on ki,, and assume that system A obeys Michaelis-Menten kinetics. It can be shown (40) As a result ofour tracer study, transmembrane inward flux oftracer MeAIB is given also by the following equation: InfluxMesIB = . * S' * VD (4), where kin is the rate constant determined in the present study, and VD is the extracellular volume of distribution of MeAIB. Note that since MeAIB is present in tracer amounts, the rate of influx is a linear function of MeAIB concentration.
By equating equations (3) and (4) 
Thus, assuming that the extracellular volume of distribution of MeAIB is invariant and that any change in the kinetic parameters of MeAIB transport is accompanied by parallel changes in the kinetic parameters of the amino acids sharing the same transport system, k,.
can increase as a consequence of an increase in transport V, (increased transport capacity), or a decrease in transport KY(increased transport affinity), or 
Results
Basal forearm muscle amino acid and potassium exchange. After the overnight fast, plasma insulin and glucose concentrations were 6.4±1.6 ,U/ml and 90±2.6 mg/dl, respectively. A significant uptake of glucose ( 1.04±0.27 mg/min per kg) was demonstrable. Deep venous total plasma amino acid concentration was higher than arterial ( 1,844±95 vs 1,754±86 MIM, P < 0.01). A net output of amino acids from forearm muscle was, therefore, documented (-2,630±1,100 nmol/min per kg). Also, deep venous plasma potassium concentration was higher than arterial (4.42±0.1 vs 4.23±0.1 mM, P < 0.05), accounting for a net potassium output from forearm muscle (-3 Fig. 2 for a typical experiment). These results document that MeAIB had gained access to a space inaccessible to mannitol. As MeAIB is specific for system A amino acid transport (24, 25) , this primary data was taken as evidence for the presence of an active system A (or system A-like) transport in human deep forearm tissues (skeletal muscle). The washout curves of mannitol and MeAIB were then analyzed using the multicompartmental model described above. The basal fractional rate of inward transmembrane Response to local hyperinsulinemia. Infusion of insulin into the brachial artery raised the deep venous insulin concentration to 76±8 AU/ml (P < 0.01), for 130 min. Insulin concentration in the contralateral arm vein showed no detectable change during the study (7±2,uU/ml). Arterial plasma amino acid and potassium concentrations did not change during the insulin infusion (1,730±106 AM and 4.10±0.08 mM, respectively, P = NS vs baseline for both). Forearm blood flow also was unchanged during the intraarterial infusion (46.4±9.2 vs 44.3±11 ml/min per kg in the postabsorptive state, P = NS).
Both amino acid and potassium concentrations in deep venous plasma decreased from the basal values (1,677±90 ,uM and 4.03+0.08 mM, P < 0.01 and P < 0.05 vs baseline values, respectively). Therefore, during the insulin infusion, there was a positive amino acid balance across forearm muscle (1,610±600 nmol/min per kg), while the potassium balance was not significantly different from zero (2,260±1,330 nmol/ min per kg). Both exchanges, however, were significantly altered when compared to the postabsorptive values (P < 0.01 for both vs baseline). Net phenylalanine and tyrosine exchanges, which, at steady state, monitor the balance between bulk protein synthesis and breakdown in forearm muscle (42, 43) , shifted from a net output in the postabsorptive state to a zero balance (-146±47 vs 16.3±51 nmol/min per kg for phenylalanine and -173±34 vs 15.5± 14.3 nmol/min per kg for tyrosine, P < 0.01 vs baseline for both), showing that bulk protein synthesis and breakdown were in equilibrium during hyperinsulinemia.
The concentrations of the system A substrates measured in the present study (glycine, alanine, threonine, asparagine, serine, and methionine) are presented in Table I . Arterial concentrations remained unchanged throughout the study, whereas venous concentrations fell significantly duringlocal hyperinsulinemia. The individual data for net balances of glycine, alanine, threonine, asparagine, serine, and methionine are shown in Table II . During insulin infusion, the net balances ofglycine, alanine, threonine, asparagine, and methionine were significantly decreased (P < 0.05-0.01 vs baseline), whereas serine showed a net positive balance (P < 0.02 vs baseline). Thus, all the naturally occurring system A substrates displayed a qualitatively similar response to insulin. The individual data of MeAIB transport also are displayed in Table II protein breakdown (1) (2) (3) (4) (5) (6) (8) (9) (10) (11) (12) (13) (14) (15) . However, the classic tracer techniques, while allowing the investigator to divide the net amino acid exchange across the limb into a protein synthetic and a protein degradative rate (43) , are unable to discern more proximal sites ofaction, which could be involved in the overall response of human muscle to insulin. The present study shows that with an appropriate experimental strategy, it is possible to gain selective information about the activity of system A amino acid transport in human deep forearm tissues. As the deep forearm tissues are almost entirely composed of skeletal muscle and, in the aggregate, all the other cellular types (e.g., endothelial cells and fibroblasts) represent a minute amount (< 2%) of the total cellular mass, the metabolic events observed in the present study primarily reflect skeletal muscle metabolism.
The multiple tracer technique used in this study was developed in analogy with the tracer technique earlier established for the assessment of glucose transport in forearm muscle (29) . Forearm blood flow is only -1% ofthe cardiac output. Consequently, the amount of tracer recirculation is negligible and local injection ofthe tracers into the brachial artery allows us to interpret the time course of the concentration in the deep vein as the result of first-pass events.
The multiple tracer dilution technique can be viewed as a system ofbuilt-in controls (33) . Since mannitol does not enter the cell and MeAIB only is transported, but not metabolized (24, 25) , and since this pair ofsubstances has comparable molecular weights, any kinetic difference between the two molecules must reflect cellular transport activity. By choosing MeAIB, according to the current operational classification of the amino acid transport systems, we selected a specific amino acid carrier (system A) for our investigation. As a result, the results that we have obtained apply only to those amino acids, whose traffic across the plasma membrane is entirely, or to a substantial extent, mediated by the system A carrier (24, 25) .
The kinetic analysis used in this study mandates that the requirements of stationarity for the tracee be fulfilled (29, 33) . On practical grounds, we achieved these conditions by performing our injections in two different steady states, as documented by constant arterial-venous substrate concentrations and constant blood flow. Moreover, because the amino acid carriers are inherently nonlinear, the amino acid concentration at the inlet must be unchanged to draw comparisons between the two steady states. This requirement also was fulfilled in the present study, as described in the results.
The present study shows that system A (or system A-like) transport activity is present in human forearm muscle and this represents the first in vivo evidence to demonstrate the presence of this insulin-stimulatable amino acid transport system in man. These results are in agreement with a previous report documenting the existence of system A transport in rat soleus muscle studied in vitro (45, 46) . An interesting feature of system A transport, as assessed by our approach, is that the rates offractional inward and outward transport differed considerably, the former being three-to fourfold greater than the latter. This finding is consistent with the well-known asymmetry of system A, which has been described by in vitro studies (24, 25) . However, it may also be caused by a higher amino acid concentration on the inner side of the plasma membrane (7), because the system A carrier is nonlinear (25) , and an increased substrate concentration would decrease the fraction ofthe cellular pool (rate constant), which is transported outside of the cell.
Among the amino acids whose transport is regulated by the activity of the system A carrier (Tables I and II) , alanine and methionine are prominent in influencing the overall amino acid metabolism of forearm muscle. It should be noted, however, that both alanine and methionine also may be carried to a substantial degree by system ASC and system L, respectively (24, 25) . Alanine plays a key role in transferring NH3 groups, produced by transamination and deamination of other amino acids, to the splanchnic tissues and in furnishing carbon atoms for hepatic gluconeogenesis (47) . Methionine has a high intracellular turnover, because it is involved in the initiation ofpeptide synthesis and in a variety oftransmethylation and transsulfuration reactions (48, 49) . It is likely, therefore, that the activ-ity of system A transport can influence some, or all, of these relevant steps of amino acid metabolism.
For both phenylalanine/tyrosine and potassium, the exposure of the forearm tissues to hyperinsulinemia shifted the balance from a net significant output (documenting that release was exceeded uptake) in the postabsorptive state to a zero net balance indicating equivalence of uptake and release (42, 43) . These results confirm previous studies (14, 15, (30) (31) (32) , and may be interpreted to reflect insulin-mediated inhibition of protein breakdown (14, 15) and stimulation of Na,K-ATPase (50), respectively.
The most relevant result of this study is that insulin increases the fractional inward transmembrane transport of amino acids that are carried by system A, while the fractional outward transport is not stimulated, or perhaps somewhat decreased. This observation shows that at least one of the sites where insulin exerts its action on forearm muscle protein metabolism involves amino acid transport across the plasma membrane. A germane question is whether this change in amino acid transport observed during hyperinsulinemia may be attributed to insulin per se, or to the insulin-induced fall in the amino acid concentration bathing the cell, which, in our study, is reflected by the decrease in venous amino acid concentration. The impact that the decrease in amino acid concentration observed during hyperinsulinemia in the present study may have on kin can be best appreciated assuming that no 
By simple recombination of (6) and (7), it follows that:
.
The Km's of system A amino acid substrates (except alanine) are at least one order ofmagnitude higher than their circulating concentrations and range between 0.9 mM for alanine and -4 mM for glycine (51 ) . By substituting the respective Km's and venous concentrations (see Table I ) in the second member of equation, it can be calculated that the decrease in alanine concentration can justify no more than a 3.3% increase in system A fractional inward transport, whereas the decrease in glycine would account for only a 0.5% increase. Thus, we think that the increase in system A fractional inward transport documented in this study (-16%) can be attributed primarily to a direct effect of insulin on system A transport. Several mechanisms may be involved in the effect ofinsulin on system A amino acid transport. During hyperinsulinemia, there was a change in potassium balance, reflecting in all likelihood an increase in Na,K-ATPase activity (30, 32, 50) and hyperpolarization of plasma membrane (52) accompanied by a steeper electrochemical sodium gradient across the cell membrane. Because amino acid transport by system A is coupled to Na+ transport (24, 25) , hyperpolarization of the cell membrane and enhanced Na+ influx would be expected to augment the inward transport of system A transported amino acids (53) . Conversely, a decrease in intracellular sodium activity might be expected to decrease the outward flux ofamino acids.
Another possibility is that insulin may play a direct role by enhancing the Km ofthe inward system while decreasing the Km of outward transport, as shown in in vitro systems. Another potential mechanism involves the antiproteolytic effect of the hormone. As elegantly shown by Gelfand and Barrett under similar experimental conditions ( 14) , insulin decreases protein breakdown, but does not increase steady state net amino acid uptake from the plasma pool. The result of inhibiting this cell-borne input of amino acid into the cellular amino acid pool should be a fall ofthe intracellular amino acid concentration. In fact, we previously have demonstrated a generalized decline in intracellular amino acid concentrations in muscle after systemic insulin infusion (7) . Since system A transport is characterized by transinhibition (24, 25), a decrease of intracellular amino acid concentration would relieve the inhibition of inward transport and increase its efficiency, while simultaneously leading to an increase in the fractional outward transport ofsystem A substrates. The latter phenomenon, which was not observed in our study, could have been offset by membrane hyperpolarization and/or decreased intracellular Na' activity induced by hyperinsulinemia. However, to our knowledge, no data are available about the behavior of intracellular muscle amino acid concentrations during combined hyperinsulinemia/euaminoacidemia, and the last potential mechanism should, therefore, be regarded as speculative.
The percent increase in inward MeAIB transport activity measured in the present study was -16%, but it is entirely consistent with the observation that all kinetic changes of forearm amino acid metabolism were brought about by decrements in the deep venous amino acid concentration of only -9-10%. Nevertheless, it could be argued that this change in amino acid transport activity is small in comparison with the changes in the rates ofamino acid exchange across the forearm tissues (Table II) . The crux of this issue is that net amino acid transport is the result of two unidirectional transmembrane fluxes. Thus, relatively little changes in either or both unidirectional fluxes are stoichiometrically compatible with major changes in the net transport of amino acids. Our results document that in the basal state, in spite of net amino acid release, the activity of the inward system A amino acid transport and, therefore, the inward movement of system A substrates across the plasma membrane is quite significant. Previous studies also have shown that, in the basal state, the forearm takes up significant amounts of labeled amino acids (e.g., phenylalanine and leucine), even though the net balance ofunlabeled substance is negative ( 14, 16, 54 ). Both lines of experimental evidence point out that the postabsorptive negative balance of amino acids in the human forearm is composed by two opposite transmembrane fluxes, whose order of magnitude is several-fold larger that the net transmembrane substrate movement. It should also be noted that not only typical system A substrates, but also phenylalanine and tyrosine shifted from a net output to a zero balance during local insulinization offorearm tissues.
The latter amino acids are substrates for the L system, which reportedly is insulin insensitive (24, 25) . Thus, the variations in the activity of transmembrane amino acid transport reported in the present study are hardly a primary causal factor of the insulin-induced changes in forearm amino acid balance, but are likely to play only an ancillary role. Yet, the potential physiologic consequences of this change in transmembrane amino acid transport deserve to be carefully appraised.
By augmenting system A transport activity, insulin would increase the transmembrane unidirectional inward flux of methionine and alanine, as long as no counterbalancing changes in the ASC and L systems occurred. This is likely to be the case because both methionine and alanine showed, indeed, a significant change in their net balance across the forearm tissues ( Table II) . Hence, more methionine would be available from the circulating pool to sustain the rates of transsulfuration, transmethylation, and methionine-tRNA formation in forearm muscle. The latter phenomenon may be of paramount importance, because the rate of methionine-tRNA synthesis must supply, not only the cells' requirements for methionine as a building block for peptides, but also for the initiation ofpeptide chains formation since methionine-tRNA is the first activated amino acid (21 ) . When viewed in this context, methionine is invested with a metabolic role which goes beyond that of simply being an essential amino acid, and, under some circumstances, its availability may become rate limiting for protein synthesis. Our results also have important relevance to the metabolism of alanine, a key gluconeogenic substrate (47) . The increased inward flux of alanine through system A in response to insulin would occur simultaneously with the inhibition of proteolysis (14, 15) , and thus limit the supply of muscle alanine for hepatic gluconeogenesis. Our findings also have relevance to the more global effect of insulin in the regulation of proteolysis and protein synthesis in forearm muscle. Inhibition of protein breakdown by insulin consistently has been shown in a number of previous studies (1) (2) (3) (4) (5) (6) (8) (9) (10) (11) (12) (13) (14) (15) (16) , but stimulation of bulk protein synthesis during hyperinsulinemia was observed only when concomitant hyperaminoacidemia occurred (3, 4, 55) . This finding, in conjunction with the observation that combined hyperinsulinemia/ hypoaminoacidemia is associated with a decrease of protein synthetic rate (1) (2) (3) (4) 16) , makes a strong case for an intracellular substrate effect of amino acids to stimulate bulk protein synthesis. However, if one holds that hyperinsulinemia per se does not directly stimulate bulk protein synthesis in vivo, it is not clear why protein synthesis does not fall under experimental conditions of hyperinsulinemia/euaminoacidemia when the insulin-induced inhibition of protein breakdown limits the intracellular source of amino acids for bulk protein synthesis (4, 14, 15) . This paradox can be resolved if either the transmembrane amino acid inward transport or the efficiency (lower Km and/or higher Vm.) of the rate determining step(s) of protein synthesis are increased by hyperinsulinemia. Our data show that the former mechanism holds for at least one amino acid transport system and demonstrate that coordinated effects and multiple sites are involved in the regulation by insulin of amino acid/protein metabolism in human skeletal muscle.
